Postprandial metabolism of docosapentaenoic acid (DPA, 22:5n-3) and eicosapentaenoic acid (EPA, 20:5n-3) in humans

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 4, 2013, Pages 313-319

  Linderborg, Kaisa M ^a   Kaur, Gunveen ^b   Miller, Eliza ^c   Meikle, Peter J ^d   Larsen, Amy E ^e   Weir, Jacquelyn M ^d   Nuora, Anu ^a   Barlow, Christopher K ^d   Kallio, Heikki P ^a   Cameron Smith, David ^f   Sinclair, Andrew J ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b VICTORIA UNIVERSITY   (Australia)

^c DEAKIN UNIVERSITY   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e LA TROBE UNIVERSITY   (Australia)

^f UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Chylomicron; Docosahexaenoic acid (DHA); Docosapentaenoic acid (DPA); Eicosapentaenoic acid (EPA); Lipid metabolism; N 3 polyunsaturated fatty acids (PUFA)

Indexed keywords

CHYLOMICRON; DOCOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID; OLIVE OIL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGESTION; DOUBLE BLIND PROCEDURE; FAT INTAKE; FATTY ACID METABOLISM; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID ANALYSIS; LIPID COMPOSITION; LIPIDOMICS; LIPOPROTEIN BLOOD LEVEL; MASS SPECTROMETRY; MEAL; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL;

ADULT; CHYLOMICRONS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPID METABOLISM; POSTPRANDIAL PERIOD; YOUNG ADULT;

EID: 84880037257     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.01.010     Document Type: Article

References (37)

1. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009, 80:85-91.
2. Conquer J.A., Cheryk L.A., Chan E., Gentry P.A., Holub B.J. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. Thromb. Res. 1999, 96:239-250.
3. Meyer B.J., Lane A.E., Mann N.J. Comparison of seal oil to tuna oil on plasma lipid levels and blood pressure in hypertriglyceridaemic subjects. Lipids 2009, 44:827-835.
4. Mann N.J., O'Connell S.L., Baldwin K.M., Singh I., Meyer B.J. Effects of seal oil and Tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids 2010, 45:669-681.
5. Miller E., Kaur G., Larsen A., Loh S.P., Linderborg K., Weisinger H.S., Turchini G., Cameron-Smith D., Sinclair A.J. A short-term n-3 DPA supplementation study in humans. Eur. J. Nutr. 2012, 10.1007/s00394-012-0396-3.
6. Kaur G., Begg D.P., Barr D., Garg M., Cameron-Smith D., Sinclair A.J. Short-term docosapentaenoic (22:5 n-3) supplementation increases tissue docosapentaenoic acid, DHA and EPA concentration in rats. Br. J. Nutr. 2010, 130:32-37.
7. Holub B.J., Swidinsky P., Park E. Oral docosapentaenoic acid (22:5n-3) is differentially incorporated into phospholipid pools and differentially metabolized to eicosapentaenoic acid in tissues from young rats. Lipids 2011, 46:399-407.
8. Kaur G., Cameron-Smith D., Garg M., Sinclair A.J. Docosapentaenoic acid (22:5n-3): a review of its biological effects. Prog. Lipid Res. 2011, 50:28-34.
9. Abia R., Perona J.S., Pacheco Y.M., Montero E., Muriana F.J., Ruiz-Gutierrez V. Postprandial triacylglycerols from dietary virgin olive oil are selectively cleared in humans. J. Nutr. 1999, 129:2184-2191.
10. Yli-Jokipii K.M., Schwab U.S., Tahvonen R.L., Kurvinen J.-P., Mykkänen H.M., Kallio H.P.T. Triacylglycerol molecular weight and to a lesser extent, fatty acid positional distribution, affect chylomicron triacylglycerol composition in women. J. Nutr. 2002, 132:924-929.
11. Yli-Jokipii K.M., Schwab U.S., Tahvonen R.L., Kurvinen J.-P., Mykkänen H.M., Kallio H.P.T. Chylomicron and VLDL TAG structures and postprandial lipid response induced by lard and modified lard. Lipids 2003, 38:693-703.
12. Sullivan B., Williams P., Meyer B. Biomarker validation of a new food frequency questionnaire that estimates long-chain omega-3 polyunsaturated fatty acids. Lipids 2006, 41:845-850.
13. Swierk M., Williams P., Meyer B., Wilcox J., Russel K. Validation of an Australian electronic food frequency questionnaire to measure polyunsaturated fatty acid intake. Nutrition 2011, 6:641-646.
14. Ågren J.J., Hallikainen M., Vidgren H., Miettinen T.A., Gylling H. Postprandial lipemic response and lipoprotein composition in subjects with low or high cholesterol absorption efficiency. Clin. Chim. Acta 2006, 366:309-315.
15. Folch J., Lees M., Stanley G.H.S. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
16. Hamilton J.G., Comai K. Rapid separation of neutral lipids, free fatty acids and polar lipids using prepacked silica Sep-Pak columns. Lipids 1988, 23:1146-1149.
17. Christie W.W. A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J. Lipid Res. 1982, 23:1072-1075.
18. Murphy R.C., James P.F., McAnoy A.M., Krank J., Duchoslav E., Barkley R.M. Detection of the abundance of diacylglycerol and triacylglycerol molecular species in cells using neutral loss mass spectrometry. Anal. Biochem. 2007, 366:59-70.
19. Lambert J.E., Parks E.J. Postprandial metabolism of meal triglyceride in humans. Biochim. Biophys. Acta 2012, 1821:721-726.
20. Xiao C., Lewis G.F. Regulation of chylomicron production in humans. Biochim. Biophys. Acta 2012, 1821:736-746.
21. Davidson M.H. Mechanisms for hypotriglyceridemic effect of marine omega-3 fatty acids. Am. J. Cardiol. 2006, 96:27i-33i.
22. Bays H.E., Tighe A.P., Sadovsky R., Davidson M.H. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Expert. Rev. Cardiovasc. Ther. 2008, 6:391-409.
23. Park Y., Harris W.S. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J. Lipid Res. 2003, 44:455-463.
24. Dyerberg J., Madsen P., Moller J.M., Aardestrup I., Schmidt E.B. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukotrienes Ess Fatty Acids 2010, 83:137-141.
25. Lawson L.D., Hughes B.G. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem. Biophys. Res. Commun. 1988, 15:328-335.
26. Hodson L., McQuaid S.E., Karpe F., Frayn K.N., Fielding B.A. Differences in partitioning of meal fatty acids into blood lipid fractions: a comparison of linoleate, oleate, and palmitate. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E64-E71.
27. Kang J.G., Park C.-Y. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab. J. 2012, 36:13-25.
28. Phang M., Sinclair A.J., Lincz L.F., Garg M.L. Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation. Nutr. Metab. Cardiovasc. Dis. 2012, 22:109-114.
29. Salisbury A.C., Harris W.S., Amin A.P., Reid K.J., O'Keefe J.H., Spertus J.A. Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction. Am. J. Cardiol. 2012, 109:13-18.
30. Simon J.A., Hodgkins M.L., Browner W.S., Neuhaus J.M., Bernert J.T., Hulley S.B. Serum fatty acids and the risk of coronary heart disease. Am. J. Epidemiol. 1995, 142:469-476.
31. Hino A., Adachi H., Toyomasu K., Yoshida N., Enomoto M., Hiratsuka A., Hirai Y., Satoh A., Imaizumi T. Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004, 176:145-149.
32. O'Keefe J., Bell D. The post-prandial hyperglycemia/hyperlipemia hypothesis: a hidden cardiovascular risk factor?. Am. J. Cardiol. 2007, 100:899-904.
33. Boullart A.C.I., de Graaf J., Stalenhoef A.F. Serum triglycerides and risk of cardiovascular disease. Biochim. Biophys. Acta 1821, 2012:867-875.
34. Jackson K.G., Poppitt S.D., Minihane A.M. Postprandial lipemia and cardiovascular disease risk: interrelationships between dietary, physiological and genetic determinants. Atherosclerosis 2012, 220:22-33.
35. DeFilippis A.P., Blaha M.J., Jacobson T.A. Omega-3 fatty acids for cardiovascular disease. Prevention Curr. Treat. Options Cardiovasc. Med. 2010, 12:365-380.
36. Cheryk L.A., Conquer J.A., Holub B.J., Gentry P.A. Docosahexaenoic acid and docosapentaenoic acid incorporation into human platelets after 24 and 72h: inhibitory effects on platelet reactivity. Platelets 1999, 10:203-211.
37. Mozaffarian D., Wu J.H.Y. (n-3) Fatty acids and cardiovascular health: are effects of EPA and DHA shared or complimentary?. J. Nutr. 2012, 142:614S-625S.